Page last updated: 2024-10-31

methoxyamine and Glioma

methoxyamine has been researched along with Glioma in 3 studies

methoxyamine: analytical reagent for aldehydes and ketones; strong irritant, can probably produce methemoglobinemia; RN given refers to parent cpd; structure

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"This study investigated the effects of β-elemene + methoxyamine, a DNA base-excision repair inhibitor, on the inhibition of glioma growth."7.79The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine. ( Hu, J; Liu, W; Shen, F; Shen, H; Zhang, J; Zhu, Y, 2013)
"Temozolomide (TMZ) is the preferred chemotherapeutic agent in the treatment of glioma following surgical resection and/or radiation."7.77N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. ( Banze, LA; Brown, AR; Goellner, EM; Hamilton, RL; Moore, B; Sobol, RW; Svilar, D; Tang, JB; Trivedi, RN; Wang, XH, 2011)
"This study investigated the effects of β-elemene + methoxyamine, a DNA base-excision repair inhibitor, on the inhibition of glioma growth."3.79The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine. ( Hu, J; Liu, W; Shen, F; Shen, H; Zhang, J; Zhu, Y, 2013)
"Temozolomide (TMZ) is the preferred chemotherapeutic agent in the treatment of glioma following surgical resection and/or radiation."3.77N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. ( Banze, LA; Brown, AR; Goellner, EM; Hamilton, RL; Moore, B; Sobol, RW; Svilar, D; Tang, JB; Trivedi, RN; Wang, XH, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, Y1
Hu, J1
Shen, F1
Shen, H1
Liu, W1
Zhang, J1
Wang, Y1
Liu, L1
Wu, C1
Bulgar, A1
Somoza, E1
Zhu, W1
Gerson, SL1
Tang, JB1
Svilar, D1
Trivedi, RN1
Wang, XH1
Goellner, EM1
Moore, B1
Hamilton, RL1
Banze, LA1
Brown, AR1
Sobol, RW1

Other Studies

3 other studies available for methoxyamine and Glioma

ArticleYear
The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine.
    Journal of neuro-oncology, 2013, Volume: 113, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Prolifer

2013
Direct detection and quantification of abasic sites for in vivo studies of DNA damage and repair.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:8

    Topics: Animals; Base Sequence; Carbon Radioisotopes; Cell Line, Tumor; DNA Damage; DNA Repair; Female; Glio

2009
N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
    Neuro-oncology, 2011, Volume: 13, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Brain; Brain Neoplasms; Cell Line,

2011